Adline Chem Lab (BOM:524604) WACC %:2.13% (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524604 Adline Chem Lab Ltd BOM:524604
26 GF Score
Price ₹14.38
View Full Analysis

What is Adline Chem Lab WACC %?

Adline Chem Lab BOM:524604 26 WACC % is 2.13% as of Jul. 26, 2026. GuruFocus rates BOM:524604 with a GF Score™ of 26/100. Among 1,021 Drug Manufacturers companies, Adline Chem Lab ranks better than 68.27% on this metric.

As of today (2026-07-26), Adline Chem Lab's weighted average cost of capital is 2.13%%. Adline Chem Lab's ROIC % is 0.00% (calculated using TTM income statement data). Adline Chem Lab earns returns that do not match up to its cost of capital. It will destroy value as it grows.

For a comprehensive WACC calculation, please access the WACC Calculator.


Adline Chem Lab  (BOM:524604) WACC % Explanation

Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Adline Chem Lab's weighted average cost of capital is 2.13%%. Adline Chem Lab's ROIC % is 0.00% (calculated using TTM income statement data). Adline Chem Lab earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.

2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.

3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.

4. GuruFocus uses the latest annual Interest Expense divided by the latest one-year annual average debt to get the simplified cost of debt.


Related Terms

Adline Chem Lab WACC % Historical Data

* Premium members only.

The historical data trend for Adline Chem Lab's WACC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adline Chem Lab WACC % Chart

Adline Chem Lab Annual Data
Trend
WACC %

Adline Chem Lab Semi-Annual Data
WACC %

BOM:524604 vs ZTS, UTHR: WACC % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Adline Chem Lab's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adline Chem Lab WACC % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adline Chem Lab's WACC % distribution charts can be found below:

* The bar in red indicates where Adline Chem Lab's WACC % falls into.


BOM:524604
26GF Score
Adline Chem Lab Ltd BOM:524604
WACC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adline Chem Lab WACC % Calculation

The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.

WACC=E/(E + D)*Cost of Equity+D/(E + D)*Cost of Debt*(1 - Tax Rate)

Frequently Asked Questions Learn more about WACC % →
What does a WACC % of 2.13% mean?
Adline Chem Lab (BOM:524604) has a WACC % of 2.13% as of Jul. 26, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Adline Chem Lab and its competitors. According to the industry distribution chart, Adline Chem Lab ranks #324 out of 1021 companies in the Drug Manufacturers industry, placing it in the top 31.7%.
Is Adline Chem Lab's WACC % too high?
Adline Chem Lab's current WACC % is 2.13%. The Drug Manufacturers industry median WACC % is 9.07. Adline Chem Lab's value of 2.13% is 76.5% below this industry median. Based on the distribution chart, Adline Chem Lab ranks #324 out of 1021 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Adline Chem Lab has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Adline Chem Lab's WACC % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Adline Chem Lab ranks #324 out of 1021 companies for WACC %. This puts Adline Chem Lab in the upper half of its industry. The industry median WACC % is 9.07. Adline Chem Lab's value of 2.13% is 76.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Drug Manufacturers company?
The median WACC % among Drug Manufacturers companies is 9.07, based on 1,021 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adline Chem Lab's current WACC % of 2.13% is 76.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Adline Chem Lab and its competitors. For the Drug Manufacturers industry, the median WACC % is 9.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adline Chem Lab's current WACC % is 2.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adline Chem Lab stock overvalued right now?
Adline Chem Lab (BOM:524604) has a current WACC % of 2.13%. The current WACC % is 2.13% and 76.5% below the Drug Manufacturers industry median of 9.07. Adline Chem Lab's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Adline Chem Lab (BOM:524604), the current WACC % is 2.13% as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adline Chem Lab Business Description

Address 403, S.G. Highway, Sarthik-II, Opposite Rajpath Club, Bodakdev, Ahmedabad, GJ, IND, 380054
Adline Chem Lab Ltd is mainly engaged in the manufacturing and trading of pharmaceutical chemicals, fine chemicals, agrochemical products. The segments of the group are pharmaceutical formulations nutraceuticals and Dietary. The company's products are offered to the domestic market, international market, veterinary, educational supplements, and contract manufacturing.
26GF Score

Get the complete analysis for BOM:524604

WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹14.38
Price